Zhiying Shao*†, Shalini Chaudhri‡, Meng Guo§, Longzhen Zhang¶, Daniel Rea#
Oncology Research, Vol.23, No.6, pp. 291-302, 2015, DOI:10.3727/096504016X14562725373879
Abstract Triple negative breast cancer (TNBC) is a phenotype of breast cancer with aggressive clinical behavior. Because
of the absence of optimal treatment, the prognosis of this disease is poor. The main purpose of this study was to
detect the response to neoadjuvant chemotherapy (NACT) in a TNBC cohort and compare the long-term survival between patients with and without pathological complete response (pCR). A total of 53 patients diagnosed
with TNBC from 2005 to 2013 who received NACT at the University Hospital Birmingham were enrolled in
this study. Overall survival (OS) and progression-free survival (PFS) were… More >
Login
Register
